Literature DB >> 1104721

Antimicrobial resistance and R-factor transfer among isolates of Salmonella in the northeastern United States: a comparison of human and animal isolates.

H C Neu, C E Cherubin, E D Longo, B Flouton, J Winter.   

Abstract

The antimicrobial susceptibility of 718 isolates of Salmonella from humans and of 688 isolates from animals was examined. Of the 46 different serotypes among the isolates from humans, Salmonella typhimurium accounted for 34%. Thirty percent of isolates were resistant to one or more antibiotic(s). Resistance to streptomycin was most common; resistance to tetracycline was next most common. Over 50% of isolates of S. typhimurium and Salmonella newport were resistant to four antibiotics. Resistance to tetracycline, kanamycin, and ampicillin has increased steadily during the past decade. Most strains possessed R-factors, and resistance to ampicillin, streptomycin, sulfisoxazole, tetracycline, chloramphenicol, and kanamycin (but not that to cephalothin) was transferable. Among the salmonellae commonly isolated from humans, only Salmonella enteritidis showed limited resistance to antibiotics (5.8%). Antibiotic resistance of isolates of S. typhimurium, Salmonella saint-paul, and Salmonella heidelberg from animals was similar to the resistance of isolates from humans. Resistance to kanamycin increased markedly over the level noted in previous studies. R-factor prevalence was high. Antibiograms of the isolates from animals and humans were similar, although some patterns were seen only in isolates from one source. Ampicillin resistance was more common in human isolates, and resistance to tetracycline, sulfonamide, and streptomycin was more common in animal isolates. Salmonellae of serotypes other than S. typhimurium that came from humans were less resistant to all antibiotics than were isolates from animals.

Entities:  

Mesh:

Year:  1975        PMID: 1104721     DOI: 10.1093/infdis/132.6.617

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  Antibiotic resistance among Salmonella from human and other sources in New Zealand.

Authors:  H M Heffernan
Journal:  Epidemiol Infect       Date:  1991-02       Impact factor: 2.451

2.  Salmonella susceptibility patterns in hospitals from 1975 through 1984.

Authors:  V Lorian
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

3.  Recent trends in salmonella and shigella in New York City and at Kings County Hospital.

Authors:  C Cherubin; M F Sierra; J Marr
Journal:  Bull N Y Acad Med       Date:  1979-03

Review 4.  [Resistance to antimicrobial agents. A WHO Scientific Working Group].

Authors: 
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

5.  Antibiotic susceptibilities of Salmonella species isolated at a large animal veterinary medical center: a three year study.

Authors:  C E Benson; J E Palmer; M F Bannister
Journal:  Can J Comp Med       Date:  1985-04

6.  Antibiotic resistance and R-plasmids in food chain Salmonella: evidence of plasmid relatedness.

Authors:  G S Bezanson; M Pauzé; H Lior
Journal:  Appl Environ Microbiol       Date:  1981-03       Impact factor: 4.792

7.  In vitro susceptibility of Salmonella to various antimicrobial agents, including a new cephalosporin, Ro 13-9904.

Authors:  P Y Chau; W S Ng; J Ling; K Arnold
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

8.  Antimicrobial resistance among Salmonella isolates from hospitals in Rome.

Authors:  V Falbo; A Caprioli; F Mondello; M L Cacace; S Luzi; D Greco
Journal:  J Hyg (Lond)       Date:  1982-04

9.  Salmonella serotypes and incidence of multiply-resistant Salmonellae isolated from diarrhoeal patients in Hong Kong from 1973-82.

Authors:  J Ling; P Y Chau; B Rowe
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

10.  Increasing spectrum in antimicrobial resistance of Shigella isolates in Bangladesh: resistance to azithromycin and ceftriaxone and decreased susceptibility to ciprofloxacin.

Authors:  Mahbubur Rahman; Shereen Shoma; Harunur Rashid; Shams El Arifeen; A H Baqui; A K Siddique; G B Nair; D A Sack
Journal:  J Health Popul Nutr       Date:  2007-06       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.